SNSE Company Profile and Key Details
NASDAQ : SNSE
Sensei Biotherapeutics
$26.62
-1.68-5.94%
At Close 4:00 PM59.34
BESG ScoreESG Rating
Price Chart
Stock Price Today
Sensei Biotherapeutics, Inc. (SNSE) stock surged +1.28%, trading at $26.96 on NASDAQ, up from the previous close of $26.62. The stock opened at $27.99, fluctuating between $25.03 and $27.99 in the recent session.
Stock Snapshot
26.62
Prev. Close
36.13M
Market Cap
25.025
Day Low
-1.61
P/E Ratio
-16.72
EPS (TTM)
-1.29
Cash Flow per Share
27.99
Open
1.34M
Number of Shares
27.99
Day High
65.67%
Free Float in %
2.59
Book Value
28.38K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 30, 2026 | 28.77 | 28.77 | 26.62 | 26.62 | 36.46K |
| Apr 29, 2026 | 29.11 | 29.77 | 26.31 | 28.30 | 26.15K |
| Apr 28, 2026 | 30.93 | 31.45 | 26.47 | 29.11 | 93.85K |
| Apr 27, 2026 | 31.14 | 32.40 | 30.61 | 31.54 | 11.84K |
| Apr 23, 2026 | 30.81 | 33.23 | 29.80 | 32.62 | 25.47K |
| Apr 22, 2026 | 30.96 | 31.97 | 30.93 | 31.64 | 10.71K |
| Apr 21, 2026 | 32.81 | 32.81 | 29.56 | 30.36 | 24.48K |
| Apr 20, 2026 | 32.92 | 33.83 | 30.20 | 31.39 | 64.9K |
| Apr 17, 2026 | 29.97 | 30.99 | 29.05 | 30.49 | 25.55K |
| Apr 16, 2026 | 29.10 | 30.55 | 28.75 | 29.22 | 16.23K |
| Apr 14, 2026 | 31.77 | 31.77 | 28.25 | 28.70 | 29.77K |
| Apr 13, 2026 | 29.59 | 31.02 | 29.20 | 30.15 | 42.73K |
| Apr 10, 2026 | 30.26 | 31.00 | 29.21 | 29.89 | 11.87K |
| Apr 09, 2026 | 31.50 | 32.30 | 30.30 | 30.53 | 56.97K |
| Apr 08, 2026 | 31.65 | 32.19 | 29.82 | 31.71 | 31.58K |
| Apr 07, 2026 | 33.14 | 34.70 | 28.51 | 30.19 | 52.22K |
| Apr 06, 2026 | 31.07 | 34.83 | 30.87 | 33.38 | 33.36K |
| Apr 02, 2026 | 32.90 | 36.07 | 30.04 | 31.02 | 61.39K |
| Apr 01, 2026 | 31.70 | 36.02 | 31.70 | 34.79 | 67.84K |
| Mar 31, 2026 | 23.91 | 33.00 | 22.98 | 31.52 | 109.93K |
Contact Details
About Company
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Company Information
| Employees | 14 |
| Beta | -0.11 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Stock Peers
ARGX
5.7+0.73%
argenx SE$781.72REGN20.7+3.02%
Regeneron Pharmaceuticals, Inc.$707.06UTHR0.28+0.05%
United Therapeutics Corporation$571.35MDGL-1.19-0.23%
Madrigal Pharmaceuticals, Inc.$517.39VRTX4.14+0.98%
Vertex Pharmaceuticals Incorporated$427.38KRTX0.09+0.03%
Karuna Therapeutics, Inc.$329.83PRAX-4.36-1.35%
Praxis Precision Medicines, Inc.$318.83ALNY8.3+2.76%
Alnylam Pharmaceuticals, Inc.$309.49KRYS2.31+0.89%
Krystal Biotech, Inc.$262.26LGND4.59+2.04%
Ligand Pharmaceuticals Incorporated$229.45Company Overview
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) closed at $26.96 USD, gaining $0.34 (1.28%) from the previous close of $26.62. The stock is currently mid-range between its 52-week high and low $5.26 and $36.76. With a market capitalization of about $36.13 million, Sensei Biotherapeutics, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.10). Key stats such as the average daily volume over the past year has been around 294.31 thousand shares, volume is running light vs its 52-week average. Headquartered in Rockville, MD, Sensei Biotherapeutics, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Christopher W. Gerry, the company employs approximately 14 people and listed since February 04, 2021. Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer.
Technical Performance
Short-term trend indicators are bearishly aligned (SMA20 79.46%, SMA50 137.15%, SMA200 215.72%). The stock’s 14-day RSI is 74.18 (overbought), while the ATR of 3.5 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.79% below its high and over 504.4% above its low. Average 10-day trading volume of 34.08 thousand shares is below the 3-month average of 311.51 thousand, indicating normal recent market interest.
Dividend & Fair Value
Sensei Biotherapeutics, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $5.68. This means the shares are trading above this model’s fair value.
Earnings & Analyst Outlook
Sensei Biotherapeutics, Inc. generated EPS of -$21.31 over the past year. Five-year average earnings growth is -11.38%. The latest quarter delivered EPS of -$3.74. The next quarter is forecast at $nan. Next year's EPS is expected at $6.90. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $30.00 to $30.00. The high target offers 12.7% upside. The low target suggests 12.7% downside. The mean target is $30.00. This offers 12.7% upside. Sensei Biotherapeutics, Inc. earnings surprise history is a mixed track record. The quarter that ended March 30, 2026, missed forecasts by -22.25%. The prior quarter beat by -11.86%. Over the last six quarters, Apple has recorded several small beats. These include -6.45% in November 14, 2024.
Shareholding & Insider Activity
Sensei Biotherapeutics, Inc. has 1.26 million shares outstanding. The public float is 828.30 thousand shares, elevated short interest at 0.94% of float. This equals 7.93 thousand shares. The short ratio is 0.76 days. Institutional investors hold 18.71% of the float. Insiders own 30.19%. RICKS THOMAS G holds 341.77 thousand shares, Cambrian BioPharma Inc has 155.14 thousand shares and Peyer James has 155.14 thousand shares. Over the past six months, insider transactions show net selling. They sold 14.08 thousand shares across 7 transactions.
Financial & Profitability Overview
On valuation metrics, Sensei Biotherapeutics trades at a P/E of -1.62, P/S of -7.49 and P/B of 1.84. The current ratio is 5.06 and quick ratio is 5.06. Debt-to-equity is 0.08, supported by a cash flow-to-debt ratio of -13.55.
Quarterly Financial Highlights
The company ended the quarter with $65.76M in cash and short-term investments, a total debt of $6.21M, and net debt of - $6.80M. Total assets were $74.37M, with equity of $64.89M. Financials further reflected weakness, with operating cash flow of - $32.02M, free cash flow of - $32.20M, and capital expenditures of - $180.00K.
Frequently Asked Questions
What is the current Sensei Biotherapeutics, Inc. (SNSE) stock price?
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) stock price is $26.96 in the last trading session. During the trading session, SNSE stock reached the peak price of $27.99 while $25.03 was the lowest point it dropped to. The percentage change in SNSE stock occurred in the recent session was 1.28% while the dollar amount for the price change in SNSE stock was $0.34.
SNSE's industry and sector of operation?
The NASDAQ listed SNSE is part of Biotechnology industry that operates in the broader Healthcare sector. Sensei Biotherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of SNSE?
Mr. John K. Celebi M.B.A., MBA
Pres, Chief Executive Officer & Director
Ms. Erin Colgan
Chief Financial Officer
Dr. Robert Hamilton Pierce M.D.
Chief R&D Officer
Mr. Edward van der Horst Ph.D.
Senior Vice President of Biologics Discovery & Early Devel.
Ms. Elisabeth Colunio
Vice President of HR
Dr. Steven A. Fuller
Chief Biopharmaceuticals Devel. Officer
Dr. Steven A. Fuller Ph.D.
Chief Biopharmaceuticals Devel. Officer
Dr. Edward Van der Horst Ph.D.
Chief Scientific Officer
Mr. Patrick Stephen Gallagher M.B.A., M.P.H.
Chief Bus. Officer
Mr. Christopher W. Gerry J.D.
Gen. Counsel & Sec.
Mr. Christopher Gerry J.D.
Vice President & Gen. Counsel
Pres, Chief Executive Officer & Director
Ms. Erin Colgan
Chief Financial Officer
Dr. Robert Hamilton Pierce M.D.
Chief R&D Officer
Mr. Edward van der Horst Ph.D.
Senior Vice President of Biologics Discovery & Early Devel.
Ms. Elisabeth Colunio
Vice President of HR
Dr. Steven A. Fuller
Chief Biopharmaceuticals Devel. Officer
Dr. Steven A. Fuller Ph.D.
Chief Biopharmaceuticals Devel. Officer
Dr. Edward Van der Horst Ph.D.
Chief Scientific Officer
Mr. Patrick Stephen Gallagher M.B.A., M.P.H.
Chief Bus. Officer
Mr. Christopher W. Gerry J.D.
Gen. Counsel & Sec.
Mr. Christopher Gerry J.D.
Vice President & Gen. Counsel
How SNSE did perform over past 52-week?
SNSE's closing price is 406.08% higher than its 52-week low of $5.26 where as its distance from 52-week high of $36.76 is -27.58%.
How many employees does SNSE have?
Number of SNSE employees currently stands at 14.
Link for SNSE official website?
Official Website of SNSE is: https://www.senseibio.com
How do I contact SNSE?
SNSE could be contacted at phone 240 243 8000 and can also be accessed through its website. SNSE operates from 451 D Street, Rockville, MD 02210, United States.
How many shares of SNSE are traded daily?
SNSE stock volume for the day was 28.38K shares. The average number of SNSE shares traded daily for last 3 months was 294.31K.
What is the market cap of SNSE currently?
The market value of SNSE currently stands at $36.13M with its latest stock price at $26.96 and 1.34M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep